A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. 1987

A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
Dept. of Medicine, Umeå Hospital, Sweden.

Sixty-four patients with active distal ulcerative colitis participated in a multicentre, randomized, investigator-blind trial to compare the effect of budesonide enema, 2 mg/100 ml, with prednisolone disodium phosphate enema, 31.25 mg/100 ml. Budesonide is a new potent corticosteroid with a rapid first-pass elimination. The patients were treated for 4 weeks, and the efficacy of the drugs were evaluated by sigmoidoscopy, histology, and subjective symptoms after 2 and 4 weeks. After 4 weeks of treatment 16 of 31 patients (52%) receiving budesonide enema had healed endoscopically, compared with 8 of 33 (24%) (p = 0.045) receiving prednisolone enema. Budesonide was superior to prednisolone in terms of both significantly improved sigmoidoscopic and histologic scores and subjective symptoms evaluated by visual analogue scales. The patients receiving prednisolone had a significant depression of endogenous cortisol levels during the treatment period, but not the patients receiving budesonide. Budesonide enema seems to be a promising therapy for active distal ulcerative colitis and causes no adverse reactions.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011282 Pregnenediones Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures. Diketopregnenes,Dioxopregnenes
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004733 Enema Insertion of a solution or compound through the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures. Enemata,Enemas,Enematas
D005260 Female Females

Related Publications

A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
December 1994, Alimentary pharmacology & therapeutics,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
February 1991, Journal of clinical gastroenterology,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
June 1986, The American journal of gastroenterology,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
July 1992, Gut,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
April 1998, Alimentary pharmacology & therapeutics,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
October 1995, Alimentary pharmacology & therapeutics,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
November 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
October 1989, Scandinavian journal of gastroenterology,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
January 1992, Journal of gastroenterology and hepatology,
A Danielsson, and G Hellers, and E Lyrenäs, and R Löfberg, and A Nilsson, and O Olsson, and S A Olsson, and T Persson, and L Salde, and J Naesdal
August 1993, Scandinavian journal of gastroenterology,
Copied contents to your clipboard!